TCF — Theracryf Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Theracryf, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	9.03	5	2	4.11	1.54
Net Total Accounts Receivable
Net Total Receivables	0.483	1.02	0.972	1.01	0.649
Prepaid Expenses
Total Current Assets	9.58	6.13	3.03	5.17	2.29
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.005	0.003	0.001	—	0.01
Net Intangible Assets
Other Long Term Assets
Total Assets	9.64	6.17	3.06	7.63	4.81
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.411	0.833	0.723	1.66	1.69
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	0.411	0.833	0.721	1.66	2.1
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	9.23	5.34	2.34	5.97	2.72
Total Liabilities & Shareholders' Equity	9.64	6.17	3.06	7.63	4.81
Total Common Shares Outstanding